Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

AGA is a common hair loss disorder, and early diagnosis and treatment with minoxidil or finasteride can help reduce emotional distress.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Intralesional corticosteroids are the best for limited alopecia areata, oral steroids are less effective, and PRP is safe and promising, especially for children and severe cases.

Stopping Cyclosporine A led to hair regrowth in a child with alopecia.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Lower PPARγ levels and specific gene variations are linked to more severe Frontal Fibrosing Alopecia.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Clobetasol and pimecrolimus are similarly effective for alopecia areata, but pimecrolimus has fewer side effects and is preferred for long-term use.

CD2 might be a new treatment target for patchy alopecia areata.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Stopping azathioprine improved hair loss and bone marrow issues.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

JAK inhibitors can help regrow hair in alopecia areata but have potential long-term risks and require careful monitoring.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

People with alopecia areata often have lower levels of zinc and vitamin D.

People with alopecia have a higher risk of thyroid cancer.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

A genetic marker linked to a type of hair loss was found in most patients studied.

Low-dose naltrexone may help reduce redness in certain scalp conditions.

Best treatment for Frontal Fibrosing Alopecia is 5-alpha-reductase inhibitors and intralesional corticosteroids.

Folliculitis Decalvans and Frontal Fibrosing Alopecia can coexist in people with darker skin, showing features of both conditions.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.